Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Guidelines highlight gaps in research evidence
| The first 150 words of the full text of this article appear below. |
EDITOR
The clinical effectiveness support unit of the Royal College of
Obstetricians and Gynaecologists has recently developed the guideline
of the National Institute for Clinical Excellence (NICE) on the use of
electronic fetal monitoring.1 One of the potential
benefits of guidelines is to highlight gaps in research evidence. As part of the guideline development process we
conducted a survey of maternity units in England and Wales to evaluate
the current use of electronic fetal monitoring in intrapartum
care.2
The guideline recommends that in women who are healthy and have an
uncomplicated pregnancy, intermittent auscultation is a suitable method
of monitoring during labour. This recommendation was based on the
evidence from nine randomised controlled trials that have enrolled
18 000 and are included in three systematic reviews.1
This conclusion was reached because screening with continuous
electronic fetal monitoring should not be conducted in the absence of
evidence of benefit. This